Dabrafenib-Trametinib Combo Approved for Pediatric Gliomas Dabrafenib-Trametinib Combo Approved for Pediatric Gliomas

The targeted therapy combination beat chemotherapy on progression-free survival, but there was no difference in overall survival at the interim analysis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news